Clinical trials
MG clinical trials
Below are recruiting mg clinical trials, each written for real people, not researchers. We’re tracking 936 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07217509Enrolling by invitation
Myasthenia gravis drug safety registry
This study tracks the safety and effectiveness of newer drugs for myasthenia gravis. If you have started or are about to start a new medication for MG, this registry can help doctors learn more about how well these treatments work in real life.
Waltham, MassachusettsAges 18 years+ - NCT07216235RecruitingPhase 3
Long-term study of saroglitazar for PBC with cirrhosis
This study tests a new drug called saroglitazar to see if it can improve long-term outcomes in people with primary biliary cholangitis (PBC) who have cirrhosis. It may be an option if you are already on UDCA or cannot take it, and if your liver function tests meet certain levels.
Marietta, GeorgiaAges 18 years+ - NCT07215884RecruitingPhase 1
Dopamine and movement in people who stutter
This study looks at how dopamine affects speech and movement in adults who stutter. It may help us understand why stuttering happens.
San Francisco, CaliforniaAges 18–65 - NCT07214207RecruitingPhase 2
Testing a sleep medicine for alcohol use disorder and stress-related drinking
This trial tests whether a medicine called suvorexant, which is used for sleep, can help people with alcohol use disorder drink less, especially when stressed. You would receive the medicine or a placebo, and researchers will track your drinking and stress levels over several weeks.
Columbus, OhioAges 18–65 - NCT07215325RecruitingPhase 4
Can doxycycline prevent STIs in men?
This trial tests if taking doxycycline after sex can lower the risk of getting sexually transmitted infections (STIs) in men who have sex with men and are at higher risk.
Atlanta, GeorgiaAges 18 years+ - NCT07217912RecruitingPhase 2
Study of daridorexant to prevent confusion after heart surgery
This trial tests whether a sleep medication called daridorexant can help prevent delirium (sudden confusion) in older adults after heart surgery. You must be 60 or older and having a specific type of heart operation.
Rochester, New YorkAges 60 years+ - NCT07214155RecruitingPhase 1
How different cannabis strains affect your experience
This study tests different strains of cannabis to see how they change your perception, feelings, and behavior. It may help you understand how cannabis affects you personally.
Baltimore, MarylandAges 21–55 - NCT07217938RecruitingPhase 2
Testing statins for swallowing problems after radiation
This study tests whether a common cholesterol-lowering drug (pravastatin, a type of statin) can reduce swallowing problems caused by past radiation for head and neck cancer. If you have had radiation at least 2 years ago and still have trouble swallowing, this trial may help find a new way to ease those symptoms.
Melbourne, VictoriaAges 18 years+ - NCT07213349RecruitingPhase 2
Daridorexant for Alzheimer's prevention
This study tests whether daridorexant, a medication that helps improve sleep, can prevent Alzheimer's disease. If you have mild memory concerns but not dementia, this trial may help find out if better sleep can protect your brain.
Montreal, QuebecAges 50–90 - NCT03903835RecruitingPhase 3
Biomarker-guided treatment for metastatic prostate cancer
This Phase 3 trial tests a prostate cancer treatment plan chosen using your tumor’s biomarker results. It aims to improve outcomes for men with metastatic prostate cancer starting first systemic treatment.
AalstAges 18 years+ - NCT07205887RecruitingPhase 2
Study of EYE103 for wet AMD or macular edema after BRVO
This trial tests an investigational drug called EYE103 injected into the eye to treat two conditions: wet age-related macular degeneration (AMD) or macular edema following a branch retinal vein occlusion (BRVO). It looks at how safe and effective the drug is for people who have not had treatment before or have not responded well to previous treatments.
Scottsdale, ArizonaAges 18 years+ - NCT06927375RecruitingPhase 4
Combination drug therapy for thyroid eye disease
This study tests a combination of two drugs, tocilizumab and flupentixol-melitracen, in people with active, moderate-to-severe thyroid-associated eye disease (TED). It aims to see if this combination can reduce eye bulging, double vision, and anxiety symptoms.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06930287Recruiting
Shoe Effects for Runners with Tight Calves
This study looks at how different types of running shoes affect runners with tight calf muscles (functional equinus). It explores whether certain footwear can help improve comfort or performance.
SalamancaAges 18–50 - NCT05974462RecruitingPhase 3
Steroids for mild heart inflammation with weaker pumping
This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.
Edegem, AntwerpAges 18–69 - NCT06779136RecruitingPhase 3
Study of MG-K10 for prurigo nodularis
This trial tests an investigational drug called MG-K10 for people with prurigo nodularis, a skin condition that causes intense itching and bumps. The goal is to see if it can help reduce itch and improve skin.
Beijing, BejingAges 18–80 - NCT07198919Enrolling by invitationPhase 1/Phase 2
Pain relief during root canal for infected tooth: gel vs. antibiotic paste
This trial compares two medicines placed inside a tooth after root canal cleaning to see which reduces pain better between appointments. If you have an infected single-root tooth and are between 16-45 years old, you may be able to join.
Karachi, SindhAges 16–45 - NCT05578586Recruiting
Study testing how to give meropenem in the ICU
This pilot study looks at the best way to give meropenem antibiotic to ICU patients with a serious suspected or confirmed infection. It may help improve treatment timing and dosing to fight infection while in intensive care.
OsloAges 18 years+ - NCT06929507Recruiting
Faricimab eye injections and kidney function in diabetes
This trial tests whether faricimab, an eye injection for certain eye conditions, affects kidney function in people with diabetes. It is for those with diabetic macular edema, wet age-related macular degeneration, or macular edema from a vein blockage, who are already taking kidney-protective medications.
Alexandroupoli, EvrosAges Any age - NCT06942520RecruitingPhase 2
Gene therapy for diabetic macular edema in adults
This trial tests a gene therapy called RGX-314 for people with diabetic macular edema that affects the center of the vision. If you have had previous treatment and still have swelling, this study may be an option.
Reno, NevadaAges 25–89 - NCT07184619RecruitingPhase 3
Evenamide for hard-to-treat schizophrenia (add-on study)
This trial tests a new medication, evenamide, added to your current antipsychotic treatment. It looks to see if it can help people whose schizophrenia has not responded well to standard therapies.
Los Angeles, CaliforniaAges 18 years+ - NCT07187570RecruitingPhase 3
Dapagliflozin to prevent atrial fibrillation recurrence after cardioversion
This trial tests if the diabetes drug dapagliflozin can lower the chance of atrial fibrillation (an irregular heartbeat) coming back after a procedure called electrical cardioversion, which uses a shock to restore a normal heart rhythm. If you have AF and are scheduled for cardioversion, you may be able to join.
LinköpingAges 55 years+ - NCT07185347RecruitingPhase 3
Fampridine for SCA27B ataxia study
This trial tests if fampridine, a medication, can improve walking and coordination in people with SCA27B, a specific inherited ataxia. It compares fampridine to a placebo over a period of time.
AngersAges 18 years+ - NCT07193264Recruiting
Caffeine's effect on blood health in healthy adults
This study looks at how regular or no caffeine intake affects your blood system. It aims to understand if caffeine changes blood cell counts and immune function.
Zurich, Canton of ZurichAges 18 years+ - NCT07185724RecruitingPhase 4
Ketorolac for fresh embryo transfer in IVF
This trial tests whether a medicine called ketorolac (a type of NSAID, similar to ibuprofen) can improve outcomes when you have a fresh embryo transfer during IVF. It may help reduce cramping or inflammation that could affect implantation.
Iowa City, IowaAges 18–37
Hear when a new MG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mg?
- Yes. Clin2 currently lists 936 recruiting mg studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mg trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mg trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.